Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1036981

registered interest
date	07/01/2019
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Gatwick Airport Station
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Baroness Sugg on 11 December 2018 (HL11834), in view of the proportion of airport passengers using Gatwick Airport railway station, what assessment they have made of requesting Gatwick Airport Limited to make a greater contribution to the costs of improving the station.
tabling member printed	Lord Bradshaw
uin	HL12623
answer	answer is ministerial correction date of answer 21/01/2019 answer text <p>The Department for Transport has been seeking to agree Gatwick Airport Limited’s contribution to the costs of enhancement works at Gatwick Airport Station through a process of negotiation.</p><p> </p><p>The objective of these negotiations has been to secure an appropriate level of contribution from the airport, which also recognises that the enhancement works are designed to improve passenger journeys for airport and non-airport users.</p><p> </p><p>Negotiations with Gatwick Airport Limited are still ongoing.</p><p> </p> answering member printed Baroness Sugg question first answered 21/01/2019 16:31:03 answering member 4584 label Biography information for Baroness Sugg
tabling member	2483 label Biography information for Lord Bradshaw

1036982

registered interest
date	07/01/2019
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Asylum
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how many of those who have claimed asylum after arriving in the UK by crossing the Channel are (1) Iranian Christians, and (2) from minorities other than Iranian Christians persecuted for their religious beliefs.
tabling member printed	Lord Alton of Liverpool
uin	HL12624
answer	answer is ministerial correction date of answer 21/01/2019 answer text <p>Over 500 migrants, the majority of whom are Iranian nationals, attempted to travel to the UK on small vessels in 2018. The vast majority of those attempts were made in the last three months of the year.</p><p>All asylum claims made in the UK are processed, managed and decided in line with Home Office policy, guidance and relevant case law and legislation. This supports an efficient and effective asylum process for the UK and en-sures that asylum claims are handled in a manner that is appropriate to the individual, including ensuring any reasonable adjustments and safeguarding needs are considered.</p><p>All asylum claimants must be treated with dignity and fairness regardless of their age, disability, ethnicity, nationality, race, gender, sexual orientation, gender identity, religion or belief.</p><p>However, the Home Office does not electronically record the grounds on which an individual claims asylum and so we cannot identify how many asy-lum claimants, from those crossing the Channel are Iranian Christians and from minorities other than Iranian Christians persecuted for their religious beliefs.</p> answering member printed Baroness Williams of Trafford question first answered 21/01/2019 17:14:39 answering member 4311 label Biography information for Baroness Williams of Trafford
tabling member	738 label Biography information for Lord Alton of Liverpool

1036983

registered interest
date	07/01/2019
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Motor Vehicles: Tyres
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Baroness Sugg on 10 December 2018 (HL11832), how many roadside checks, which involved checks on whether buses, coaches, or lorries have a tyre fitted which is more than ten years old, were conducted in the last three years for which figures are available; and how many such cases were referred by the Driver and Vehicle Standards Agency to the Office of the Traffic Commissioner.
tabling member printed	Lord Bradshaw
uin	HL12625
answer	answer is ministerial correction date of answer 21/01/2019 answer text <p>The Driver and Vehicle Standards Agency (DVSA) carried out the following number of roadside checks (mechanical checks/encounters) involving buses, coaches and lorries, in the last 3 calendar years. All mechanical encounters involve a check of the condition of a tyre irrespective of its age.</p><p> </p><table><tbody><tr><td><p>2016</p></td><td><p>2017</p></td><td><p>2018</p></td></tr><tr><td><p>117,600</p></td><td><p>114,965</p></td><td><p>105,471</p></td></tr></tbody></table><p> </p><p>Buses and coaches have been checked from June 2017 to identify if they have a tyre that is more than ten years old fitted on the front axle. When conducting roadside checks, the DVSA has a process in place to identify tyres that are more than 10 years old, irrespective of condition, and will conduct follow up investigations with operators.</p><p><strong> </strong></p><p>No such cases have been referred by the DVSA to the Office of the Traffic Commissioner since the referral process began in December 2018.</p> answering member printed Baroness Sugg question first answered 21/01/2019 18:01:54 answering member 4584 label Biography information for Baroness Sugg
tabling member	2483 label Biography information for Lord Bradshaw

1036984

registered interest
date	07/01/2019
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Large Goods Vehicles: Safety
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answer by Baroness Sugg on 18 December 2018 (HL12016), what value was put on a life lost, or a serious injury, in coming to a decision about retrofitting of safeguards on heavy goods vehicles.
tabling member printed	Lord Bradshaw
uin	HL12626
answer	answer is ministerial correction date of answer 21/01/2019 answer text <p>The analysis used economic values from official Government and Department for Transport Appraisal Guidance (TAG), Table A 4.1.1: Average value of prevention per casualty by severity and element of cost.</p><p>The economic values were approximately £1.6m for a fatal casualty and £0.18m for a serious casualty (2010 prices, 2015 TAG version).</p> answering member printed Baroness Sugg question first answered 21/01/2019 16:35:02 answering member 4584 label Biography information for Baroness Sugg
tabling member	2483 label Biography information for Lord Bradshaw

1036985

registered interest
date	07/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether the proposed changes to the Human Medicines Regulation 2012, as outlined in the document Further guidance note on the regulation of medicines, medical devices and clinical trials if there’s no Brexit deal, published on 4 January, would (1) be used rarely, (2) be time limited, and (3) only apply in the event that there is no significant disruption to the supply of medicines in the event of a no deal Brexit.
tabling member printed	Lord Warner
uin	HL12627
answer	answer is ministerial correction date of answer 21/01/2019 answer text <p>As part of the preparations for a ‘no deal’ exit from the European Union, the Department developed proposals for and informally consulted with the relevant stakeholder representative bodies on a power to modify the application of the Human Medicines Regulation 2012 to deal with serious shortages in the event of a ‘no deal’ exit. This power can only be used in the case of a ‘no deal’ exit from the EU, only have effect until two years after exit day and only apply in the case of a serious shortage where one but not the only significant factor contributing to the shortage is the withdrawal of the United Kingdom from the EU.</p><p>The legal provisions will clarify that a serious shortage is a serious shortage in the opinion of Ministers.</p> answering member printed Baroness Manzoor grouped question UIN HL12628 question first answered 21/01/2019 16:41:23 answering member 4289 label Biography information for Baroness Manzoor
tabling member	1732 label Biography information for Lord Warner

1036986

registered interest
date	07/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they intend to include in the proposed changes to the Human Medicines Regulation 2012, as outlined in the document Further guidance note on the regulation of medicines, medical devices and clinical trials if there’s no Brexit deal, published on 4 January, a legal definition of “serious national shortages of medicines” in any accompanying statutory instruments, to ensure that proposed changes would be (1) time limited, and (2) apply only in the event that there is a significant disruption to the supply of medicines in the event of a no deal Brexit.
tabling member printed	Lord Warner
uin	HL12628
answer	answer is ministerial correction date of answer 21/01/2019 answer text <p>As part of the preparations for a ‘no deal’ exit from the European Union, the Department developed proposals for and informally consulted with the relevant stakeholder representative bodies on a power to modify the application of the Human Medicines Regulation 2012 to deal with serious shortages in the event of a ‘no deal’ exit. This power can only be used in the case of a ‘no deal’ exit from the EU, only have effect until two years after exit day and only apply in the case of a serious shortage where one but not the only significant factor contributing to the shortage is the withdrawal of the United Kingdom from the EU.</p><p>The legal provisions will clarify that a serious shortage is a serious shortage in the opinion of Ministers.</p> answering member printed Baroness Manzoor grouped question UIN HL12627 question first answered 21/01/2019 16:41:24 answering member 4289 label Biography information for Baroness Manzoor
tabling member	1732 label Biography information for Lord Warner

1036987

registered interest
date	07/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, in relation to the proposed changes to the Human Medicines Regulation 2012, as outlined in the document Further guidance note on the regulation of medicines, medical devices and clinical trials if there’s no Brexit deal, published on 4 January, what supply triggers would be applied under the “Serious Shortage Protocol” for pharmacists to dispense (1) reduced quantities of medicine, (2) alternate dosage forms, (3) generic versions of the prescription-only medicine substitution, (4) similar medicinal products, and (5) medicines that have a similar therapeutic effect; whether there will be a full risk assessment performed for the types of medication and clinical circumstances to be included in the protocol; and whether this protocol will be (a) legally defined, and (b) developed with clinical experts.
tabling member printed	Lord Warner
uin	HL12629
answer	answer is ministerial correction date of answer 21/01/2019 answer text <p>A serious shortage protocol would only be introduced in case of a serious shortage, if it would help manage the supply situation and if clinicians think it is appropriate. A protocol is only one of the tools that can be used to manage shortages. The Department manages shortages in collaboration with manufacturers and suppliers, the National Health Service and the Medicines and Healthcare products Regulatory Agency and will continue to do so. For each shortage the Department assesses the risk to patients and decides what tools to use to mitigate the impact on patients which could include a serious shortage protocol. The triggers for considering a protocol and the protocol itself will be different depending on the medicines and the supply situation, including whether alternatives are available.</p><p>The legal provisions will clarify that a serious shortage is a serious shortage in the opinion of Ministers.</p><p>Any serious shortage protocol would be developed with and signed off by clinicians. Only if clinicians deem it appropriate, an alternative quantity, strength, pharmaceutical form or medicine can be dispensed in line with the protocol. Each protocol would clearly set out what alternative can be dispensed by the retail pharmacy, under what circumstances, for which patients and during which period.</p> answering member printed Baroness Manzoor question first answered 21/01/2019 16:42:21 answering member 4289 label Biography information for Baroness Manzoor
tabling member	1732 label Biography information for Lord Warner

1036988

registered interest
date	07/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether the “Serious Shortage Protocol”, as set out in the document Further guidance note on the regulation of medicines, medical devices and clinical trials if there’s no Brexit deal, published on 4 January, will be applied to patients involved in clinical trials; and what assessment they have made of the risk of jeopardising the conduct of clinical trials and the data collected by the application of the protocol to such trials.
tabling member printed	Lord Warner
uin	HL12630
answer	answer is ministerial correction date of answer 21/01/2019 answer text <p>The provisions exempt retail pharmacies from dispensing against a prescription when a serious shortage protocol is in place. We do not envisage it would apply to medicines not supplied on prescription, including those supplied as part of a clinical trial. Therefore, no such assessment has been made.</p> answering member printed Baroness Manzoor question first answered 21/01/2019 16:42:45 answering member 4289 label Biography information for Baroness Manzoor
tabling member	1732 label Biography information for Lord Warner

1036989

registered interest
date	07/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether they will be conducting a full impact assessment of the effect on patients of the proposed changes to the Human Medicines Regulation 2012, as outlined in the document Further guidance note on the regulation of medicines, medical devices and clinical trials if there’s no Brexit deal, published on 4 January.
tabling member printed	Lord Warner
uin	HL12631
answer	answer is ministerial correction date of answer 21/01/2019 answer text <p>An impact assessment will be published alongside the Statutory Instruments when they are laid in Parliament.</p> answering member printed Baroness Manzoor question first answered 21/01/2019 16:43:01 answering member 4289 label Biography information for Baroness Manzoor
tabling member	1732 label Biography information for Lord Warner

1036990

registered interest
date	07/01/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, in relation to the proposed changes to the Human Medicines Regulation 2012, as outlined in the document Further guidance note on the regulation of medicines, medical devices and clinical trials if there’s no Brexit deal, published on 4 January, what will constitute a ‘serious shortage’ in the Serious Shortage Protocol; how such a circumstance will be determined by the Department of Health and Social Care; what is the procedure for determining the content of the Serious Shortage Protocol; what governance processes will be applied to the protocol including how (1) manufacturers, and (2) Market Authorisation Holders will be engaged in any governance; and whether manufacturers must be the primary party to establish which products are listed as being in “serious shortage”.
tabling member printed	Lord Warner
uin	HL12632
answer	answer is ministerial correction date of answer 21/01/2019 answer text <p>The legal provisions will clarify that a serious shortage is a serious shortage in the opinion of Ministers.</p><p>A protocol is only one of the tools that can be used to manage shortages. The Department has well-established governance processes for managing shortages in collaboration with manufacturers and suppliers, clinicians and the National Health Service and the Medicines and Healthcare products Regulatory Agency. A protocol would only be introduced in case of a serious shortage, if it would help manage the supply situation and if clinicians think it is appropriate, after discussion with the manufacturer and/or marketing authorisation holder.</p><p>Whether a serious shortage protocol is issued is a decision by Ministers but that decision would be taken after discussion with the manufacturer and/or marketing authorisation holder. Manufacturers are not the primary party to establish which products are listed as being in serious shortage.</p><p> </p> answering member printed Baroness Manzoor question first answered 21/01/2019 16:44:02 answering member 4289 label Biography information for Baroness Manzoor
tabling member	1732 label Biography information for Lord Warner